If people are willing to hold long term and if the plant commissioning occurs without too much trouble, then any past valuation here should be bargain. JM115 covered some good points of why caution persists. I'll add that once AGY demonstrate the scale up via commissioning which often is notoriously tricky (the fact that AGY have produced tons of carbonate already bodes well here), then that will automatically prove to investors that the company's method/approach works at scale and that the planned scale up to 12kt will be just a matter of copy and paste. Investors being forward thinking will likely induce a big rerate once confirmation occurs. I think all this news will drop near each other in future (licence, offtakes, production etc) with some likely depending on the other. So I agree with you, patience is needed. One of the most valuable lessons I've learnt over the years, is that often the best approach is simply to trade less if you've done your research.
- Forums
- ASX - By Stock
- AGY
- Ann: Rincon 2,000tpa Li2CO3 Operations Update
Ann: Rincon 2,000tpa Li2CO3 Operations Update, page-75
-
-
- There are more pages in this discussion • 180 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.002(5.26%) |
Mkt cap ! $58.23M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.8¢ | $203.5K | 5.180M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 676315 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 1312029 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 676315 | 0.039 |
3 | 112110 | 0.038 |
12 | 1041553 | 0.037 |
24 | 2519053 | 0.036 |
28 | 2709206 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 1312029 | 9 |
0.041 | 853002 | 6 |
0.042 | 2324272 | 7 |
0.043 | 1762500 | 3 |
0.044 | 286335 | 5 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online